Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 37 Prostatic Neoplasms 12 Triple Negative Breast Neoplasms 4 Pancreatic Neoplasms 4 Ovarian Neoplasms 4 Liver Neoplasms 3 Fibrosis 3 Endometrial Neoplasms 3 Carcinoma, Renal Cell 3 Carcinoma, Intraductal, Noninfiltrating 3 Uterine Cervical Neoplasms 2 Thyroid Nodule 2 Stomach Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pleural Effusion, Malignant 2 Neoplasms 2 Mouth Neoplasms 2 Melanoma 2 Lymphoma 2 Lymphedema 2 Leukemia, Myeloid, Acute 2 Leukemia 2 Inflammatory Breast Neoplasms 2 Infertility 2 Hodgkin Disease 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Medullary 2 Carcinoma, Hepatocellular 2 Anatomic Stage III Breast Cancer AJCC v8 2

Interventions

Standard of Care 2 tocilizumab 1 pazopanib 1 Tomography, X-Ray Computed 1 Practice Guidelines as Topic 1 Operative Blood Salvage 1 Molecular Imaging 1 Methods 1 Magnetic Resonance Spectroscopy 1 Lenalidomide 1 Interviews as Topic 1 Immunoglobulin G 1 High-Energy Shock Waves 1 Educational Status 1 Early Intervention, Educational 1 Disulfides 1 Cardiac Surgical Procedures 1 Breathing Exercises 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Coronary Artery Disease × High-Energy Shock Waves × Clear all

NCT01230905 2017-04-24

AST

Ottawa Heart Institute Research Corporation

Phase 4 Completed

Coronary Artery Disease, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡